ARQT logo

ARQT
Arcutis Biotherapeutics Inc

2,495
Mkt Cap
$3.21B
Volume
1.32M
52W High
$31.77
52W Low
$11.13
PE Ratio
-73.91
ARQT Fundamentals
Price
$26.20
Prev Close
$26.65
Open
$26.41
50D MA
$28.32
Beta
1.40
Avg. Volume
1.95M
EPS (Annual)
-$1.16
P/B
19.94
Rev/Employee
$574,684.21
Loading...
Loading...
News
all
press releases
Interesting ARQT Put And Call Options For September 18th
Investors in Arcutis Biotherapeutics Inc (Symbol: ARQT) saw new options become available this week, for the September 18th expiration. One of the key inputs that goes into the price an option buyer...
Nasdaq News: Markets·4d ago
News Placeholder
More News
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr.
Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT). In a filing disclosed on January 12th, the Representative disclosed that...
MarketBeat·10d ago
News Placeholder
Strength Seen in ANI (ANIP): Can Its 10.6% Jump Turn into More Strength?
ANI (ANIP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·12d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Trading Down 7.3% - Here's What Happened
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 7.3% - Here's Why...
MarketBeat·12d ago
News Placeholder
Howard Welgus Sells 10,000 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) Director Howard Welgus sold 10,000 shares of the business's stock in a transaction that occurred on Friday, January 2nd. The stock was...
MarketBeat·18d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Raised to "Strong-Buy" at Wall Street Zen
Wall Street Zen upgraded Arcutis Biotherapeutics from a "buy" rating to a "strong-buy" rating in a report on Sunday...
MarketBeat·21d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $49,552.40 in Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Patrick Burnett sold 1,697 shares of the company's stock in a transaction that occurred on Wednesday, December 31st. The shares...
MarketBeat·22d ago
News Placeholder
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) has been given an average rating of "Moderate Buy" by the nine research firms that are presently covering the stock, MarketBeat Ratings...
MarketBeat·24d ago
News Placeholder
Wednesday's ETF Movers: XBI, SLVR
In trading on Wednesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 0.7% on the day. Components of that ETF showing particular strength include shares of Oruka Therapeutics, up...
Nasdaq News: Markets·24d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Trading Up 3.4% - Still a Buy?
Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Up 3.4% - Should You Buy...
MarketBeat·24d ago
<
1
2
...
>

Latest ARQT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.